annual CAPEX:
$8.40B+$1.01B(+13.68%)Summary
- As of today (April 12, 2025), LLY annual capital expenditures is $8.40 billion, with the most recent change of +$1.01 billion (+13.68%) on December 31, 2024.
- During the last 3 years, LLY annual CAPEX has risen by +$6.43 billion (+324.77%).
- LLY annual CAPEX is now at all-time high.
Performance
LLY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$1.75B-$2.42B(-58.11%)Summary
- As of today (April 12, 2025), LLY quarterly capital expenditures is $1.75 billion, with the most recent change of -$2.42 billion (-58.11%) on December 31, 2024.
- Over the past year, LLY quarterly CAPEX has stayed the same.
- LLY quarterly CAPEX is now -58.11% below its all-time high of $4.17 billion, reached on September 30, 2024.
Performance
LLY quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$8.40B+$96.10M(+1.16%)Summary
- As of today (April 12, 2025), LLY TTM capital expenditures is $8.40 billion, with the most recent change of +$96.10 million (+1.16%) on December 31, 2024.
- Over the past year, LLY TTM CAPEX has stayed the same.
- LLY TTM CAPEX is now at all-time high.
Performance
LLY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
LLY CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.7% | 0.0% | 0.0% |
| 3 y3 years | +324.8% | +93.4% | +179.4% |
| 5 y5 years | +520.9% | +93.4% | +179.4% |
LLY CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +324.8% | -58.1% | +173.6% | at high | +255.0% |
| 5 y | 5-year | at high | +520.9% | -58.1% | +544.0% | at high | +586.5% |
| alltime | all time | at high | +2194.2% | -58.1% | >+9999.0% | at high | +5055.6% |
Eli Lilly and Company CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $8.40B(+13.7%) | $1.75B(-58.1%) | $8.40B(+1.2%) |
| Sep 2024 | - | $4.17B(+197.3%) | $8.31B(+2.1%) |
| Jun 2024 | - | $1.40B(+29.6%) | $8.14B(+7.5%) |
| Mar 2024 | - | $1.08B(-34.4%) | $7.57B(+2.4%) |
| Dec 2023 | $7.39B(+147.6%) | $1.65B(-58.7%) | $7.39B(+15.9%) |
| Sep 2023 | - | $4.00B(+378.4%) | $6.38B(+110.5%) |
| Jun 2023 | - | $836.30M(-7.4%) | $3.03B(+0.8%) |
| Mar 2023 | - | $903.50M(+41.5%) | $3.01B(+0.8%) |
| Dec 2022 | $2.99B(+50.9%) | $638.60M(-2.1%) | $2.99B(+4.9%) |
| Sep 2022 | - | $652.10M(-19.9%) | $2.85B(+7.4%) |
| Jun 2022 | - | $813.60M(-7.7%) | $2.65B(+11.9%) |
| Mar 2022 | - | $881.00M(+76.4%) | $2.37B(+19.7%) |
| Dec 2021 | $1.98B(-2.5%) | $499.40M(+9.6%) | $1.98B(-13.9%) |
| Sep 2021 | - | $455.60M(-14.2%) | $2.30B(+1.8%) |
| Jun 2021 | - | $531.30M(+8.0%) | $2.26B(+0.4%) |
| Mar 2021 | - | $492.10M(-40.0%) | $2.25B(+10.9%) |
| Dec 2020 | $2.03B(+49.9%) | $819.50M(+97.4%) | $2.03B(+32.1%) |
| Sep 2020 | - | $415.10M(-20.7%) | $1.54B(+5.1%) |
| Jun 2020 | - | $523.20M(+92.8%) | $1.46B(+19.4%) |
| Mar 2020 | - | $271.30M(-16.9%) | $1.22B(-9.6%) |
| Dec 2019 | $1.35B(-55.2%) | $326.50M(-4.3%) | $1.35B(-18.0%) |
| Sep 2019 | - | $341.10M(+19.6%) | $1.65B(+2.6%) |
| Jun 2019 | - | $285.30M(-28.8%) | $1.61B(-49.4%) |
| Mar 2019 | - | $400.60M(-35.8%) | $3.18B(+5.4%) |
| Dec 2018 | $3.02B(+39.5%) | $623.70M(+108.0%) | $3.02B(+4.5%) |
| Sep 2018 | - | $299.80M(-83.9%) | $2.89B(-4.9%) |
| Jun 2018 | - | $1.86B(+685.7%) | $3.04B(+117.0%) |
| Mar 2018 | - | $236.50M(-52.1%) | $1.40B(-35.3%) |
| Dec 2017 | $2.16B(+98.1%) | $493.50M(+10.2%) | $2.16B(+1.3%) |
| Sep 2017 | - | $447.70M(+102.0%) | $2.13B(+11.5%) |
| Jun 2017 | - | $221.60M(-77.9%) | $1.91B(-1.2%) |
| Mar 2017 | - | $1.00B(+115.3%) | $1.94B(+77.5%) |
| Dec 2016 | $1.09B(-32.8%) | $464.80M(+104.3%) | $1.09B(-7.6%) |
| Sep 2016 | - | $227.50M(-7.3%) | $1.18B(-7.5%) |
| Jun 2016 | - | $245.40M(+59.0%) | $1.28B(-8.2%) |
| Mar 2016 | - | $154.30M(-72.2%) | $1.39B(-14.4%) |
| Dec 2015 | $1.63B(+3.9%) | $554.20M(+71.3%) | $1.63B(-11.6%) |
| Sep 2015 | - | $323.50M(-10.1%) | $1.84B(-1.0%) |
| Jun 2015 | - | $359.90M(-7.4%) | $1.86B(+6.0%) |
| Mar 2015 | - | $388.60M(-49.3%) | $1.75B(+11.9%) |
| Dec 2014 | $1.57B(+43.2%) | $767.10M(+124.4%) | $1.57B(+16.5%) |
| Sep 2014 | - | $341.90M(+34.1%) | $1.34B(+7.0%) |
| Jun 2014 | - | $254.90M(+26.2%) | $1.26B(+10.4%) |
| Mar 2014 | - | $202.00M(-62.9%) | $1.14B(+4.0%) |
| Dec 2013 | $1.09B(+4.7%) | $545.20M(+114.8%) | $1.09B(+9.5%) |
| Sep 2013 | - | $253.80M(+86.1%) | $998.10M(+3.9%) |
| Jun 2013 | - | $136.40M(-13.6%) | $960.40M(-7.5%) |
| Mar 2013 | - | $157.90M(-64.9%) | $1.04B(-0.6%) |
| Dec 2012 | $1.04B(-38.3%) | $450.00M(+108.2%) | $1.04B(+19.0%) |
| Sep 2012 | - | $216.10M(+1.1%) | $877.30M(-13.1%) |
| Jun 2012 | - | $213.80M(+30.1%) | $1.01B(-24.5%) |
| Mar 2012 | - | $164.30M(-42.0%) | $1.34B(-21.0%) |
| Dec 2011 | $1.69B(+42.7%) | $283.10M(-18.8%) | $1.69B(+0.5%) |
| Sep 2011 | - | $348.60M(-35.7%) | $1.68B(+10.9%) |
| Jun 2011 | - | $542.20M(+4.5%) | $1.52B(-0.8%) |
| Mar 2011 | - | $519.00M(+89.2%) | $1.53B(+29.0%) |
| Dec 2010 | $1.19B(+38.8%) | $274.30M(+49.8%) | $1.19B(-5.8%) |
| Sep 2010 | - | $183.10M(-67.0%) | $1.26B(+0.7%) |
| Jun 2010 | - | $554.20M(+216.5%) | $1.25B(+43.2%) |
| Mar 2010 | - | $175.10M(-49.5%) | $873.10M(+2.1%) |
| Dec 2009 | $855.00M(-20.0%) | $346.80M(+99.0%) | $855.00M(+9.1%) |
| Sep 2009 | - | $174.30M(-1.5%) | $783.90M(-5.6%) |
| Jun 2009 | - | $176.90M(+12.7%) | $830.50M(-13.0%) |
| Mar 2009 | - | $157.00M(-43.1%) | $955.00M(-10.7%) |
| Dec 2008 | $1.07B(-1.2%) | $275.70M(+24.8%) | $1.07B(-7.8%) |
| Sep 2008 | - | $220.90M(-26.7%) | $1.16B(-0.8%) |
| Jun 2008 | - | $301.40M(+11.1%) | $1.17B(+5.0%) |
| Mar 2008 | - | $271.20M(-26.0%) | $1.11B(+2.9%) |
| Dec 2007 | $1.08B | $366.70M(+59.4%) | $1.08B(-3.8%) |
| Sep 2007 | - | $230.10M(-6.5%) | $1.13B(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $246.20M(+2.8%) | $1.17B(+1.3%) |
| Mar 2007 | - | $239.40M(-41.6%) | $1.16B(+7.3%) |
| Dec 2006 | $1.08B(-17.0%) | $410.00M(+48.7%) | $1.08B(-0.9%) |
| Sep 2006 | - | $275.70M(+19.1%) | $1.09B(+1.6%) |
| Jun 2006 | - | $231.40M(+44.0%) | $1.07B(-12.0%) |
| Mar 2006 | - | $160.70M(-61.7%) | $1.22B(-6.3%) |
| Dec 2005 | $1.30B(-31.6%) | $419.60M(+62.3%) | $1.30B(-3.7%) |
| Sep 2005 | - | $258.60M(-31.5%) | $1.35B(-12.8%) |
| Jun 2005 | - | $377.70M(+55.9%) | $1.55B(-7.8%) |
| Mar 2005 | - | $242.20M(-48.5%) | $1.68B(-11.7%) |
| Dec 2004 | $1.90B(+11.2%) | $470.00M(+3.0%) | $1.90B(-9.0%) |
| Sep 2004 | - | $456.40M(-10.2%) | $2.09B(+3.7%) |
| Jun 2004 | - | $508.10M(+9.6%) | $2.01B(+6.4%) |
| Mar 2004 | - | $463.60M(-29.5%) | $1.89B(+10.8%) |
| Dec 2003 | $1.71B(+50.9%) | $657.80M(+72.0%) | $1.71B(+18.5%) |
| Sep 2003 | - | $382.40M(-1.4%) | $1.44B(+4.5%) |
| Jun 2003 | - | $387.80M(+39.2%) | $1.38B(+13.2%) |
| Mar 2003 | - | $278.60M(-28.7%) | $1.22B(+7.6%) |
| Dec 2002 | $1.13B(+27.9%) | $390.90M(+22.1%) | $1.13B(+7.4%) |
| Sep 2002 | - | $320.20M(+41.0%) | $1.05B(+9.6%) |
| Jun 2002 | - | $227.10M(+17.9%) | $961.20M(+4.2%) |
| Mar 2002 | - | $192.70M(-38.5%) | $922.70M(+4.4%) |
| Dec 2001 | $884.00M(+30.4%) | $313.40M(+37.5%) | $884.00M(+8.4%) |
| Sep 2001 | - | $228.00M(+20.9%) | $815.50M(+9.5%) |
| Jun 2001 | - | $188.60M(+22.5%) | $744.50M(+3.1%) |
| Mar 2001 | - | $154.00M(-37.1%) | $721.90M(+6.5%) |
| Dec 2000 | $677.90M(+28.3%) | $244.90M(+56.0%) | $677.90M(+5.7%) |
| Sep 2000 | - | $157.00M(-5.4%) | $641.10M(+28.5%) |
| Jun 2000 | - | $166.00M(+50.9%) | $499.00M(-9.9%) |
| Mar 2000 | - | $110.00M(-47.1%) | $553.60M(+4.8%) |
| Dec 1999 | $528.30M(+25.8%) | $208.10M(+1296.6%) | $528.30M(+11.0%) |
| Sep 1999 | - | $14.90M(-93.2%) | $476.00M(-7.1%) |
| Jun 1999 | - | $220.60M(+160.4%) | $512.40M(+20.0%) |
| Mar 1999 | - | $84.70M(-45.6%) | $426.90M(+1.7%) |
| Dec 1998 | $419.90M(+14.6%) | $155.80M(+203.7%) | $419.90M(+0.8%) |
| Sep 1998 | - | $51.30M(-62.0%) | $416.70M(-6.0%) |
| Jun 1998 | - | $135.10M(+73.9%) | $443.10M(+15.0%) |
| Mar 1998 | - | $77.70M(-49.1%) | $385.30M(+5.2%) |
| Dec 1997 | $366.30M(-17.5%) | $152.60M(+96.4%) | $366.30M(+23.5%) |
| Sep 1997 | - | $77.70M(+0.5%) | $296.70M(-14.5%) |
| Jun 1997 | - | $77.30M(+31.7%) | $347.10M(-13.5%) |
| Mar 1997 | - | $58.70M(-29.3%) | $401.50M(-9.6%) |
| Dec 1996 | $443.90M(-19.5%) | $83.00M(-35.2%) | $443.90M(-14.5%) |
| Sep 1996 | - | $128.10M(-2.7%) | $519.10M(-3.6%) |
| Jun 1996 | - | $131.70M(+30.3%) | $538.40M(-3.1%) |
| Mar 1996 | - | $101.10M(-36.1%) | $555.50M(+0.8%) |
| Dec 1995 | $551.30M(-4.4%) | $158.20M(+7.3%) | $551.30M(-11.3%) |
| Sep 1995 | - | $147.40M(-0.9%) | $621.20M(+8.8%) |
| Jun 1995 | - | $148.80M(+53.6%) | $571.10M(+1.7%) |
| Mar 1995 | - | $96.90M(-57.5%) | $561.50M(-2.6%) |
| Dec 1994 | $576.50M(-9.0%) | $228.10M(+134.4%) | $576.50M(+2.8%) |
| Sep 1994 | - | $97.30M(-30.1%) | $560.80M(-6.6%) |
| Jun 1994 | - | $139.20M(+24.4%) | $600.60M(-1.1%) |
| Mar 1994 | - | $111.90M(-47.3%) | $607.40M(-4.1%) |
| Dec 1993 | $633.50M(-36.8%) | $212.40M(+54.9%) | $633.50M(-21.8%) |
| Sep 1993 | - | $137.10M(-6.1%) | $810.40M(+2.0%) |
| Jun 1993 | - | $146.00M(+5.8%) | $794.20M(-15.8%) |
| Mar 1993 | - | $138.00M(-64.6%) | $943.00M(-5.9%) |
| Dec 1992 | $1.00B(-12.3%) | $389.30M(+222.0%) | $1.00B(+5.9%) |
| Sep 1992 | - | $120.90M(-59.0%) | $946.40M(-14.8%) |
| Jun 1992 | - | $294.80M(+49.6%) | $1.11B(+1.4%) |
| Mar 1992 | - | $197.10M(-40.9%) | $1.09B(-4.2%) |
| Dec 1991 | $1.14B(+13.4%) | $333.60M(+17.0%) | $1.14B(-6.4%) |
| Sep 1991 | - | $285.20M(+2.2%) | $1.22B(+4.7%) |
| Jun 1991 | - | $279.00M(+14.1%) | $1.16B(+7.0%) |
| Mar 1991 | - | $244.60M(-40.5%) | $1.09B(+8.1%) |
| Dec 1990 | $1.01B(+81.7%) | $411.30M(+78.9%) | $1.01B(+69.0%) |
| Sep 1990 | - | $229.90M(+13.2%) | $596.00M(+62.8%) |
| Jun 1990 | - | $203.10M(+24.6%) | $366.10M(+124.6%) |
| Mar 1990 | - | $163.00M | $163.00M |
| Dec 1989 | $554.50M | - | - |
FAQ
- What is Eli Lilly and Company annual capital expenditures?
- What is the all time high annual CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company annual CAPEX year-on-year change?
- What is Eli Lilly and Company quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly CAPEX year-on-year change?
- What is Eli Lilly and Company TTM capital expenditures?
- What is the all time high TTM CAPEX for Eli Lilly and Company?
- What is Eli Lilly and Company TTM CAPEX year-on-year change?
What is Eli Lilly and Company annual capital expenditures?
The current annual CAPEX of LLY is $8.40B
What is the all time high annual CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high annual capital expenditures is $8.40B
What is Eli Lilly and Company annual CAPEX year-on-year change?
Over the past year, LLY annual capital expenditures has changed by +$1.01B (+13.68%)
What is Eli Lilly and Company quarterly capital expenditures?
The current quarterly CAPEX of LLY is $1.75B
What is the all time high quarterly CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly capital expenditures is $4.17B
What is Eli Lilly and Company quarterly CAPEX year-on-year change?
Over the past year, LLY quarterly capital expenditures has changed by $0.00 (0.00%)
What is Eli Lilly and Company TTM capital expenditures?
The current TTM CAPEX of LLY is $8.40B
What is the all time high TTM CAPEX for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM capital expenditures is $8.40B
What is Eli Lilly and Company TTM CAPEX year-on-year change?
Over the past year, LLY TTM capital expenditures has changed by $0.00 (0.00%)